Genentech education campaign urges flu sufferers to mind their manners

Share this article:
Genentech education campaign urges flu sufferers to mind their manners
Genentech education campaign urges flu sufferers to mind their manners
Genentech is sponsoring a flu education campaign featuring hereditary etiquette expert Anna Post offering advice to the flu-stricken on keeping the bug to themselves.

The “Are You That Guy?” effort, for which Genentech is partnering with the National Foundation for Infectious Diseases, features a website (flufacts.com), Facebook page and media outreach touting a survey on how people handle the flu. Post, the great-great-granddaughter of Emily Post and co-author of the 18th edition of Emily Post's Etiquette, appears in videos and a factsheet with guidance on being a considerate sickie.

“No one wants to be ‘That Guy' who spreads the flu to family, friends, or colleagues,” said Post. “Knowing how to politely cancel an event you're hosting or how to avoid shaking your client's hand because you're sick can be difficult and potentially awkward.  By following appropriate flu etiquette, we can all play a role in preventing the spread of the flu virus.”

Visitors to the website or Facebook page can download a “Fight the Flu” iPhone app featuring a flu tracker, quizzes and polls and email alerts about flu rates in their area. The website also features a symptom checker and doctor discussion guide, along with a Q&A-style edu-game and plenty of quirky animation. It's all unbranded, though the utility of antivirals in flu treatment and prevention is heavily emphasized. Genentech manufactures the antiviral flu-fighter Tamiflu.

The survey of 1,044 US adults found that 64% had gone about their regular daily activities despite being wracked with flu sometime in the past three years, even though 81% agreed that people sick with the flu should cancel social obligations to avoid infecting others. Little more than a third (36%) said they'd call their doctor if they thought they had the flu, and 37% said they are uncomfortable telling flu sufferers that they should stay home.
Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...